Wai Chun Bio-Technology Limited (0660.HK)
HKD 0.08
(0.0%)
HKD 0.08
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 128.02 Million HKD | -10.95% |
| 2021 | 143.76 Million HKD | 15.62% |
| 2020 | 124.33 Million HKD | 32.47% |
| 2019 | 93.85 Million HKD | 2.45% |
| 2018 | 91.61 Million HKD | 15.73% |
| 2017 | 79.16 Million HKD | 22.84% |
| 2016 | 64.43 Million HKD | -8.06% |
| 2015 | 70.09 Million HKD | 43.79% |
| 2014 | 48.74 Million HKD | 70.48% |
| 2013 | 28.59 Million HKD | -78.21% |
| 2012 | 131.24 Million HKD | 79.62% |
| 2011 | 73.06 Million HKD | 100.93% |
| 2010 | 36.36 Million HKD | 430.29% |
| 2009 | -11.01 Million HKD | -306.87% |
| 2008 | -2.7 Million HKD | -105.62% |
| 2007 | 48.13 Million HKD | 1127.47% |
| 2006 | -4.68 Million HKD | 77.53% |
| 2005 | -20.84 Million HKD | 20.4% |
| 2004 | -26.18 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 132.11 Million HKD | 0.53% |
| 2023 Q3 | 131.4 Million HKD | 2.64% |
| 2023 Q2 | 128.02 Million HKD | 1.32% |
| 2023 Q1 | 126.35 Million HKD | -9.14% |
| 2022 Q2 | 143.76 Million HKD | 0.0% |
| 2022 FY | 128.02 Million HKD | -10.95% |
| 2022 Q3 | 139.06 Million HKD | -3.27% |
| 2022 Q4 | 139.06 Million HKD | 0.0% |
| 2021 Q2 | 134.49 Million HKD | 2.83% |
| 2021 Q1 | 130.79 Million HKD | 5.2% |
| 2021 Q3 | 139.56 Million HKD | 3.77% |
| 2021 Q4 | 142.72 Million HKD | 2.26% |
| 2021 FY | 143.76 Million HKD | 15.62% |
| 2020 FY | 124.33 Million HKD | 32.47% |
| 2020 Q1 | 97.76 Million HKD | 4.16% |
| 2020 Q2 | 97.76 Million HKD | 0.0% |
| 2020 Q3 | 120.74 Million HKD | 23.5% |
| 2020 Q4 | 124.33 Million HKD | 2.97% |
| 2019 Q1 | 90.98 Million HKD | -0.68% |
| 2019 Q4 | 93.85 Million HKD | 0.0% |
| 2019 Q3 | 93.85 Million HKD | 3.15% |
| 2019 Q2 | 90.98 Million HKD | 0.0% |
| 2019 FY | 93.85 Million HKD | 2.45% |
| 2018 Q2 | 81.76 Million HKD | 0.0% |
| 2018 FY | 91.61 Million HKD | 15.73% |
| 2018 Q4 | 91.61 Million HKD | 0.0% |
| 2018 Q3 | 91.61 Million HKD | 12.04% |
| 2018 Q1 | 81.76 Million HKD | 3.3% |
| 2017 Q2 | 80.03 Million HKD | -13.14% |
| 2017 FY | 79.16 Million HKD | 22.84% |
| 2017 Q3 | 89.06 Million HKD | 11.27% |
| 2017 Q4 | 79.16 Million HKD | -11.12% |
| 2017 Q1 | 92.15 Million HKD | 43.01% |
| 2016 Q4 | 64.43 Million HKD | -18.43% |
| 2016 Q1 | 71.8 Million HKD | 2.44% |
| 2016 Q2 | 52.29 Million HKD | -27.17% |
| 2016 FY | 64.43 Million HKD | -8.06% |
| 2016 Q3 | 79 Million HKD | 51.07% |
| 2015 Q3 | 86.41 Million HKD | 11.44% |
| 2015 Q2 | 77.54 Million HKD | 0.0% |
| 2015 Q1 | 77.54 Million HKD | 59.08% |
| 2015 FY | 70.09 Million HKD | 43.79% |
| 2015 Q4 | 70.09 Million HKD | -18.89% |
| 2014 Q1 | 75.55 Million HKD | 164.25% |
| 2014 FY | 48.74 Million HKD | 70.48% |
| 2014 Q4 | 48.74 Million HKD | -36.17% |
| 2014 Q3 | 76.37 Million HKD | 76.2% |
| 2014 Q2 | 43.34 Million HKD | -42.63% |
| 2013 Q2 | 27.09 Million HKD | 697.49% |
| 2013 Q3 | 41.72 Million HKD | 54.0% |
| 2013 Q4 | 28.59 Million HKD | -31.48% |
| 2013 FY | 28.59 Million HKD | -78.21% |
| 2013 Q1 | -4.53 Million HKD | -103.46% |
| 2012 FY | 131.24 Million HKD | 79.62% |
| 2012 Q4 | 131.24 Million HKD | 0.0% |
| 2012 Q2 | 62.72 Million HKD | 0.0% |
| 2011 FY | 73.06 Million HKD | 100.93% |
| 2011 Q4 | 73.06 Million HKD | 0.0% |
| 2011 Q2 | 36.07 Million HKD | 0.0% |
| 2010 FY | 36.36 Million HKD | 430.29% |
| 2010 Q2 | -5.8 Million HKD | 0.0% |
| 2010 Q4 | 36.36 Million HKD | 0.0% |
| 2009 FY | -11.01 Million HKD | -306.87% |
| 2009 Q4 | -11.01 Million HKD | 0.0% |
| 2008 FY | -2.7 Million HKD | -105.62% |
| 2007 FY | 48.13 Million HKD | 1127.47% |
| 2006 FY | -4.68 Million HKD | 77.53% |
| 2005 FY | -20.84 Million HKD | 20.4% |
| 2004 FY | -26.18 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Lee & Man Chemical Company Limited | 415.24 Million HKD | 69.17% |